Addition of metformin to exogenous glucagon-like peptide–1 results in increased serum glucagon-like peptide–1 concentrations and greater glucose lowering in type 2 diabetes mellitus
Joy Cuthbertson, Steven Patterson, Finbarr P. O'Harte, Patrick M. BellVolume:
60
Year:
2011
Language:
english
Pages:
5
DOI:
10.1016/j.metabol.2010.01.001
File:
PDF, 251 KB
english, 2011